Current Role of Chemotherapy in Nonmetastatic Nasopharyngeal Cancer

被引：28

作者：

Bhattacharyya, Tapesh ^{[1
]}

Babu, Geethu ^{[2
]}

Kainickal, Cessal Thommachan ^{[2
]}

机构：

[1] Tata Med Ctr, Div Radiat Oncol, Kolkata, India

[2] Reg Canc Ctr, Div Radiat Oncol, Trivandrum, Kerala, India

来源：

JOURNAL OF ONCOLOGY | 2018年 / 2018卷

关键词：

BARR-VIRUS DNA; PLUS ADJUVANT CHEMOTHERAPY; RANDOMIZED PHASE-II; CONCURRENT CHEMORADIOTHERAPY; THERAPEUTIC GAIN; CARCINOMA; RADIOTHERAPY; TRIAL; MULTICENTER; FRACTIONATION;

D O I：

10.1155/2018/3725837

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Nasopharyngeal carcinoma is highly radio-and chemosensitive tumor with its unique clinical and biological behavior. Treatment of stage I disease is radical radiotherapy alone. For stage II disease treatment is radiotherapy with or without chemotherapy. The standard of care for locally advanced nasopharyngeal cancer (stages III-IVB) is concurrent chemoradiation. Optimum timing and sequence of chemotherapy are not yet well-defined. The role of adjuvant and induction chemotherapy is debatable. Here we are going to highlight the role of chemotherapy in nasopharyngeal carcinoma, its benefit, and controversies regarding timing and sequences.

引用

页数：7

共 36 条

[1] Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].

Al-Sarraf, M ;

LeBlanc, M ;

Giri, PGS ;

Fu, KK ;

Cooper, J ;

Vuong, T ;

Forastiere, AA ;

Adams, G ;

Sakr, WA ;

Schuller, DE ;

Ensley, JF .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317

[2] Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients [J].

Baujat, B ;

Audry, W ;

Bourhis, J ;

Chan, ATC ;

Onat, H ;

Chua, DTT ;

Kwong, DLW ;

al-Sarraf, M ;

Chi, KH ;

Hareyama, M ;

Leung, SF ;

Thephamongkhol, K ;

Pignon, JP .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (01) :47-56

[3] Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis [J].

Blanchard, Pierre ;

Lee, Anne ;

Marguet, Sophie ;

Leclercq, Julie ;

Ng, Wai Tong ;

Ma, Jun ;

Chan, Anthony T. C. ;

Huang, Pei-Yu ;

Benhamou, Ellen ;

Zhu, Guopei ;

Chua, Daniel T. T. ;

Chen, Yong ;

Mai, Hai-Qiang ;

Kwong, Dora L. W. ;

Cheah, Shie Lee ;

Moon, James ;

Tung, Yuk ;

Chi, Kwan-Hwa ;

Fountzilas, George ;

Zhang, Li ;

Hui, Edwin Pun ;

Lu, Tai-Xiang ;

Bourhis, Jean ;

Pignon, Jean Pierre .

LANCET ONCOLOGY, 2015, 16 (06) :645-655

[4] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial [J].

Cao, Su-Mei ;

Yang, Qi ;

Guo, Ling ;

Mai, Hai-Qiang ;

Mo, Hao-Yuan ;

Cao, Ka-Jia ;

Qian, Chao-Nan ;

Zhao, Chong ;

Xiang, Yan-Qun ;

Zhang, Xiu-Ping ;

Lin, Zhi-Xiong ;

Li, Wei-Xiong ;

Liu, Qing ;

Qiu, Fang ;

Sun, Rui ;

Chen, Qiu-Yan ;

Huang, Pei-Yu ;

Luo, Dong-Hua ;

Hua, Yi-Jun ;

Wu, Yi-Shan ;

Lv, Xing ;

Wang, Lin ;

Xia, Wei-Xiong ;

Tang, Lin-Quan ;

Ye, Yan-Fang ;

Chen, Ming-Yuan ;

Guo, Xiang ;

Hong, Ming-Huang .

EUROPEAN JOURNAL OF CANCER, 2017, 75 :14-23

[5] Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Chan, A. T. C. ;

Gregoire, V. ;

Lefebvre, J. -L. ;

Licitra, L. ;

Hui, E. P. ;

Leung, S. F. ;

Felip, E. .

ANNALS OF ONCOLOGY, 2012, 23 :83-85

[6] A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT). [J].

Chan, Anthony T. C. ;

Hui, Edwin Pun ;

Ngan, Roger K. C. ;

Tung, Stewart Yuk ;

Cheng, Ashley Chi Kin ;

Ng, Wai Tong ;

Lee, Victor H. F. ;

Ma, Brigette ;

Cheng, Hoi Ching ;

Wong, Frank C. S. ;

Loong, Herbert H. F. ;

Tong, Macy ;

Poon, Daren M. C. ;

Ahuja, Anil Tejbhan ;

King, Ann Dorothy ;

Wang, Ki ;

Mo, Frankie ;

Zee, Benny C. Y. ;

Chan, Allen K. C. ;

Lo, Y. M. Dennis .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[7]

Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614

[8] Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial [J].

Chen, Lei ;

Hu, Chao-Su ;

Chen, Xiao-Zhong ;

Hu, Guo-Qing ;

Cheng, Zhi-Bin ;

Sun, Yan ;

Li, Wei-Xiong ;

Chen, Yuan-Yuan ;

Xie, Fang-Yun ;

Liang, Shao-Bo ;

Chen, Yong ;

Xu, Ting-Ting ;

Li, Bin ;

Long, Guo-Xian ;

Wang, Si-Yang ;

Zheng, Bao-Min ;

Guo, Ying ;

Sun, Ying ;

Mao, Yan-Ping ;

Tang, Ling-Long ;

Chen, Yu-Ming ;

Liu, Meng-Zhong ;

Ma, Jun .

EUROPEAN JOURNAL OF CANCER, 2017, 75 :150-158

[9] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial [J].

Chen, Lei ;

Hu, Chao-Su ;

Chen, Xiao-Zhong ;

Hu, Guo-Qing ;

Cheng, Zhi-Bin ;

Sun, Yan ;

Li, Wei-Xiong ;

Chen, Yuan-Yuan ;

Xie, Fang-Yun ;

Liang, Shao-Bo ;

Chen, Yong ;

Xu, Ting-Ting ;

Li, Bin ;

Long, Guo-Xian ;

Wang, Si-Yang ;

Zheng, Bao-Min ;

Guo, Ying ;

Sun, Ying ;

Mao, Yan-Ping ;

Tang, Ling-Long ;

Chen, Yu-Ming ;

Liu, Meng-Zhong ;

Ma, Jun .

LANCET ONCOLOGY, 2012, 13 (02) :163-171

[10] Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial [J].

Chen, Qiu-Yan ;

Wen, Yue-Feng ;

Guo, Ling ;

Liu, Huai ;

Huang, Pei-Yu ;

Mo, Hao-Yuan ;

Li, Ning-Wei ;

Xiang, Yan-Qun ;

Luo, Dong-Hua ;

Qiu, Fang ;

Sun, Rui ;

Deng, Man-Quan ;

Chen, Ming-Yuan ;

Hua, Yi-Jun ;

Guo, Xiang ;

Cao, Ka-Jia ;

Hong, Ming-Huang ;

Qian, Chao-Nan ;

Mai, Hai-Qiang .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (23) :1761-1770

← 1 2 3 4 →